Establishing Acceptance Limits for Uniformity of Dosage Units: Part Two

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-08-02-2017
Volume 41
Issue 8
Pages: 30–39

The author describes how to establish acceptance limits for acceptance value (AV) data for process validation batches, typical characteristics of AV distributions, and how to derive relevant constants for AV control charts in annual product review and continued process verification reports.

Africa Studio/shutterstock.com

Abstract

The concept of sampling distribution of acceptance value (AV) was introduced in Part One of this article series. In Part Two, the author describes how to establish the corresponding acceptance limits for AV data for process validation batches, the typical characteristics of AV distributions, and finally, how to derive relevant constants for AV control charts in annual product review and continued process verification reports.

Click here to view a PDF of this article.

Peer-review article
Submitted: Jan. 17, 2017
Accepted: March 8, 2017

 

About the author

Pramote Cholayudth is a validation consultant to Biolab Co., Ltd., in Thailand. He is the founder and manager of PM Consult, cpramote2000@yahoo.com.

Article Details

Pharmaceutical Technology
Vol. 41, No. 8
Pages: 30–39

Citation:

When referring to this article, please cite it as P. Cholayudth, "Establishing Acceptance Limits for Uniformity of Dosage Units: Part Two," Pharmaceutical Technology 41 (8) 2017.

 

 

 

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Related Content